India’s HPV campaign has reached a major milestone, with nearly 50 lakh girls vaccinated within just three months of the nationwide rollout.
Moderna flu vaccine moved a step closer to market approval after an independent panel of advisers to the US Food and Drug Administration (FDA) unanimously backed the company's experimental shot for adults aged 50 years and older.
Midjourney, the AI image-generation startup known for creating digital art, is making an unexpected move into healthcare.
Lupin enters hypertension drug market as it announced the commercial launch of Azilsartan Medoxomil tablets in the United States.
Specialty drugs are becoming the next big growth driver for Indian pharmaceutical companies as the industry looks beyond traditional generic medicines.
Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
.jpeg "India Pharma Growth Broadens as Volumes Gain Momentum")
India’s pharma market shows balanced growth as rising volumes, steady pricing, and new launches drive sustained expansion across therapies and regions.
.jpeg "Hyderabad Emerges as Pharma R&D Hub with Neuland's $20M Bet")
Neuland’s $20M facility in Hyderabad strengthens Genome Valley’s position as a leading pharma innovation hub focused on advanced drug development.
Zydus Lifesciences has finalized its acquisition of Assertio Holdings, strengthening its position in the US specialty pharmaceutical market and expanding its presence across several high-value therapeutic segments.
The World Health Organization (WHO) has taken a major step toward improving child-focused dengue treatment with the publication of its first-ever Paediatric Drug Optimization Process (PADO) for dengue.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")